NasdaqGS - Delayed Quote • USD
Outset Medical, Inc. (OM)
At close: May 31 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.45 | -0.37 | -1.79 | -1.17 |
| Low Estimate | -0.52 | -0.46 | -1.85 | -1.46 |
| High Estimate | -0.25 | -0.18 | -1.71 | -0.56 |
| Year Ago EPS | -0.69 | -0.71 | -2.7 | -1.79 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 31.17M | 39.83M | 146.41M | 173.64M |
| Low Estimate | 30.4M | 38M | 145M | 165.22M |
| High Estimate | 31.91M | 41.5M | 148.8M | 178.4M |
| Year Ago Sales | 36.04M | 30.39M | 130.38M | 146.41M |
| Sales Growth (year/est) | -13.50% | 31.10% | 12.30% | 18.60% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.76 | -0.67 | -0.61 | -0.55 |
| EPS Actual | -0.69 | -0.71 | -0.59 | -0.57 |
| Difference | 0.07 | -0.04 | 0.02 | -0.02 |
| Surprise % | 9.20% | -6.00% | 3.30% | -3.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.45 | -0.37 | -1.79 | -1.17 |
| 7 Days Ago | -0.45 | -0.37 | -1.79 | -1.17 |
| 30 Days Ago | -0.53 | -0.52 | -2.07 | -1.8 |
| 60 Days Ago | -0.53 | -0.52 | -2.06 | -1.8 |
| 90 Days Ago | -0.53 | -0.52 | -2.06 | -1.8 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 7 | 7 | 7 | 8 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | OM | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 34.80% | -- | -- | 8.90% |
| Next Qtr. | 47.90% | -- | -- | 11.40% |
| Current Year | 33.70% | -- | -- | 5.80% |
| Next Year | 34.60% | -- | -- | 12.60% |
| Next 5 Years (per annum) | 23.80% | -- | -- | 11.45% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | BTIG: Buy | 4/8/2024 |
| Downgrade | RBC Capital: Outperform to Sector Perform | 1/12/2024 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 12/4/2023 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 11/14/2023 |
| Maintains | RBC Capital: Outperform to Outperform | 10/13/2023 |
| Maintains | Stifel: Buy to Buy | 10/13/2023 |
Related Tickers
LUNG Pulmonx Corporation
7.25
-0.68%
SGHT Sight Sciences, Inc.
6.56
+0.61%
NARI Inari Medical, Inc.
50.00
-1.37%
NVRO Nevro Corp.
9.35
+1.96%
SWAV Shockwave Medical, Inc.
334.75
0.00%
NPCE NeuroPace, Inc.
6.91
+5.66%
TMCI Treace Medical Concepts, Inc.
5.88
+2.17%
CLPT ClearPoint Neuro, Inc.
5.43
-2.16%
INSP Inspire Medical Systems, Inc.
158.79
+2.86%
SRTS Sensus Healthcare, Inc.
5.42
-4.24%